Demineralized Bone Fiber Technology Market Report 2024

This Demineralized Bone Fiber Technology market report covers industry characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The demineralized bone fiber technology market size has grown strongly in recent years. It will grow from $1.27 billion in 2023 to $1.35 billion in 2024 at a compound annual growth rate (CAGR) of 6.3%. The growth during the historic period can be attributed to the increasing aging population, a higher incidence of bone-related injuries, an increase in spinal fusion surgeries, more government initiatives, and a greater use of stem cells.

The demineralized bone fiber technology market size is expected to see strong growth in the next few years. It will grow to $1.74 billion in 2028 at a compound annual growth rate (CAGR) of 6.5%. The growth projected for the forecast period can be attributed to the increasing prevalence of bone disorders, advancements in biomaterials and tissue engineering, a higher number of orthopedic surgeries, a growing preference for minimally invasive procedures, and a stronger focus on regenerative medicine. Key trends during this period include technological innovations, 3D printing, regenerative medicine, hybrid grafts, and personalized bone grafting solutions.

The growing incidence of orthopedic disorders is anticipated to drive the expansion of the demineralized bone fiber technology market. Orthopedic disorders, affecting bones, joints, muscles, and surrounding tissues, can impair movement and function. The rising prevalence of these disorders is influenced by factors such as an aging population, sedentary lifestyles, and increasing obesity rates, which contribute to higher rates of joint and bone-related issues. Demineralized bone fiber technology supports bone regeneration in patients with orthopedic disorders by offering a natural scaffold that promotes new bone growth. For example, in August 2023, the Institute for Health Metrics and Evaluation, a US-based public health agency, reported that 595 million people were affected by osteoarthritis in 2020, with projections indicating this number could approach 1 billion by 2050. This increasing prevalence of orthopedic disorders is expected to drive growth in the demineralized bone fiber technology market.

Key players in the demineralized bone fiber technology market are developing innovative solutions, such as proprietary demineralized cortical bone fiber technology, to advance medical and dental applications. This technology involves a specialized processing method that removes mineral content from cortical bone, resulting in bone fibers with enhanced biological and mechanical properties. For instance, in February 2024, Tetrous Inc., a US-based regenerative medicine company, introduced the EnFix TAC, a demineralized bone allograft implant designed to improve healing at the enthesis, the junction between bone and tendon, following rotator cuff surgery. Utilizing advanced demineralized bone fiber technology, the EnFix TAC enhances the integration and regeneration of bone and tendon tissues, addressing the issue of scar tissue formation that can impede proper healing. The device provides a supportive framework that facilitates efficient bone-to-tendon integration and accommodates various suture anchor systems, thus optimizing surgical outcomes.

In June 2022, Isto Biologics, a US-based company specializing in orthobiologic regeneration technology and cell-based therapies, acquired TheraCell for an undisclosed amount. This acquisition is expected to strengthen Isto’s offerings in surgical and clinical care for spine, orthopedics, and sports medicine. TheraCell, a Greece-based provider of demineralized bone fiber technology, will contribute to Isto's expanded capabilities in these areas.

Major companies operating in the demineralized bone fiber technology market are Johnson & Johnson, Medtronic Plc, Stryker Corporation, Zimmer Biomet, Arthrex Inc., Globus Medical Inc., Integra LifeSciences Corporation, NuVasive Inc., Wright Medical Group N.V., Bioventus LLC, Alphatec Holdings Inc., MTF Biologics, RTI Surgical Holdings Inc., LifeNet Health, SeaSpine Holdings Corporation, AlloSource, Xtant Medical Holdings Inc., Orthofix Medical Inc., Kuros Biosciences AG, Spine Wave Inc., Orthogen LLC.

North America was the largest region in the demineralized bone fiber technology market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the demineralized bone fiber technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the demineralized bone fiber technology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Demineralized bone fiber technology involves treating human or animal bone to remove minerals while preserving the collagen matrix, creating a flexible bone graft material. This technology is mainly used in orthopedic and dental surgeries to support bone healing and regeneration. Its osteoinductive properties aid in stimulating new bone growth at the implantation site.

The primary product types in demineralized bone fiber technology are allograft, demineralized bone matrix (DBM), synthetic, and xenograft. Allografts are bone grafts obtained from a donor, typically a deceased individual, used in surgeries to repair or replace damaged bones. The materials used include collagen, hydroxyapatite, polymers, and tricalcium phosphate. Applications are concentrated in dental procedures, joint reconstruction, spinal fusion, and trauma care. End-users of these products include ambulatory surgical centers, hospitals, and specialty clinics.

The demineralized bone fiber technology market research report is one of a series of new reports that provides demineralized bone fiber technology market statistics, including demineralized bone fiber technology industry global market size, regional shares, competitors with a demineralized bone fiber technology market share, detailed demineralized bone fiber technology market segments, market trends and opportunities, and any further data you may need to thrive in the demineralized bone fiber technology industry. This demineralized bone fiber technology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The demineralized bone fiber technology market consists of revenues earned by entities providing services such as orthopedic repairs, customized solutions, and bone regeneration. The market value includes the value of related goods sold by the service provider or included within the service offering. The demineralized bone fiber technology market also includes sales of demineralized bone fiber scaffolds, demineralized bone fiber paste, and demineralized bone fiber grafts. manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.